Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin.
Souleymane MB, Kadri S, Piubello A, Tsoumanis A, Soumana A, Issa H, Amoussa AK, Van Deun A, Lynen L, de Jong BC, Decroo T. Souleymane MB, et al. Among authors: de jong bc. Int J Infect Dis. 2023 Aug;133:78-81. doi: 10.1016/j.ijid.2023.05.002. Epub 2023 May 5. Int J Infect Dis. 2023. PMID: 37150352 Free article. Clinical Trial.
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss.
Souleymane MB, Piubello A, Lawan IM, Hassane-Harouna S, Assao-Neino MM, Soumana A, Hamidou-Harouna Z, Gagara-Issoufou A, Ortuño-Gutiérrez N, Roggi A, Schwoebel V, Mamadou S, Lynen L, De Jong B, Van Deun A, Decroo T. Souleymane MB, et al. Eur Respir J. 2021 Jan 21;57(1):2002250. doi: 10.1183/13993003.02250-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32703777 Free article.
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown.
Van Deun A, Decroo T, Aung KJM, Hossain MA, Gumusboga M, De Rijk WB, Tahseen S, de Jong BC, Rigouts L. Van Deun A, et al. Among authors: de jong bc, de rijk wb. Eur Respir J. 2021 Sep 2;58(3):2100783. doi: 10.1183/13993003.00783-2021. Print 2021 Sep. Eur Respir J. 2021. PMID: 33926970 Free article. No abstract available.
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study.
Souleymane MB, Decroo T, Mamadou S, Soumana A, Lawan IM, Gagara-Issoufou A, Adehossi E, Ortuño-Gutiérrez N, Lynen L, Rigouts L, de Jong BC, Van Deun A, Piubello A. Souleymane MB, et al. Among authors: de jong bc. Int Health. 2023 May 2;15(3):258-264. doi: 10.1093/inthealth/ihac016. Int Health. 2023. PMID: 35420123 Free PMC article.
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.
Ngabonziza JCS, Decroo T, Migambi P, Habimana YM, Van Deun A, Meehan CJ, Torrea G, Massou F, de Rijk WB, Ushizimpumu B, Niyigena EB, Ivan E, Semahore JM, Mazarati JB, Merle CS, Supply P, Affolabi D, Rigouts L, de Jong BC. Ngabonziza JCS, et al. Among authors: de jong bc, de rijk wb. Lancet Microbe. 2020 Jun;1(2):e74-e83. doi: 10.1016/S2666-5247(20)30007-0. Epub 2020 Jun 8. Lancet Microbe. 2020. PMID: 35544156 Free article.
Management of falsepositive rifampicin resistant Xpert MTB/RIF - Authors' reply.
Ngabonziza JCS, Decroo T, Torrea G, Migambi P, Van Deun A, Rigouts L, de Jong BC. Ngabonziza JCS, et al. Among authors: de jong bc. Lancet Microbe. 2020 Oct;1(6):e239. doi: 10.1016/S2666-5247(20)30125-7. Epub 2020 Oct 7. Lancet Microbe. 2020. PMID: 35544219 Free article. No abstract available.
Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
Younoussa A, Samidine SN, Bergeman AT, Piubello A, Attoumani N, Grillone SH, Braet SM, Tsoumanis A, Baco A, Mzembaba A, Salim Z, Amidy M, Grillone S, Snijders R, Corstjens P, Ortuno-Gutierrez N, Hoof C, Geluk A, de Jong BC, Hasker E. Younoussa A, et al. Among authors: de jong bc. BMC Infect Dis. 2023 May 9;23(1):310. doi: 10.1186/s12879-023-08290-0. BMC Infect Dis. 2023. PMID: 37161571 Free PMC article. Clinical Trial.
202 results